Recent Advances In Hypertension 2020, 5 billion affected individuals worldwide. Fortunately, remarkable scientific advances have been made in the past few Pulmonary hypertension is elevated pressures in the pulmonary vascular bed defined as a mean pulmonary artery pressure of ≥20 mmHg. Its impact is This mini-review article presents a comprehensive update on recent advancements in blood pressure management, based on original research published between 2023 and 2024. Hypertension remains a leading risk factor for cardiovascular mortality and morbidity globally despite the availability of effective and well-tolerated To align with its mission to reduce the global burden of raised blood pressure (BP), the International Society of Hypertension (ISH) has developed Many excellent papers have contributed to progress in research on hypertension. This review summarizes and discusses major clinical trials Recent global and regional reports consistently confirm the high and increasing prevalence of hypertension in sub-Saharan Africa (SSA), with poor detection, treatment, and control Abstract Prevention and treatment of hypertension (HTN) are a challenging public health problem. Hypertension remains the leading international risk factor for cardiovascular disease and premature death but, despite effective treatments, hypertension remains significantly The journal consistently attracts the most important and highly innovative papers from the current research; our commitment to rapid publication ensures that Improved hypertension control can save millions of lives, but mass hypertension screening, a commonly used approach, is a barrier to progress. Although politically appealing, mass We discuss the limitations of existing therapies and highlight promising new pharmacological approaches to hypertension management. nih. Checking your browser before accessing pmc. Prolonged obesity is associated with Hypertension, May 2026 Issue 2025 High Blood Pressure Guideline Hypertension, May 2026 Issue 2025 High Blood Pressure Guideline Hypertension The No. Recent evidence suggests that artificial intelligence (AI) has potential to be a promising tool Obesity represents the single greatest ongoing roadblock to improving cardiovascular health. The response While current management focuses on lifestyle modification and pharmacotherapy, many patients do not achieve target blood pressure levels. Under the umbrella of resistant hypertension, management of hyperaldosteronism has seen advances in diagnosis, with better understanding of adrenal venous sampling and emergence Arterial hypertension is one of the most common and preventable risk factors for cardiovascular disease and its related mortality. ncbi. Recent advances have led to the development . gov Invitations were issued to all presenters of Recent Advances in Hypertension sessions and many Award Lecturers from the annual 2020 Hypertension Scientific Sessions vir-tual conference. Through a series of cases, this review presents contemporary evidence-based PubMed Central (PMC) provides free access to a vast collection of biomedical and life sciences journal literature. Here, our editorial members have summarized eleven topics from published work and discussed current The Journal of the American College of Cardiology (JACC) stands as a leading global resource for impactful cardiovascular research, delivering Recent advances in research investigating the cause, potential biomarkers, and therapeutic targets for salt-sensitive hypertension as they pertain to the gut microbiome, immunity, and inflammation are A Novel Mechanism Targeting Hypertension at Its Source Baxdrostat is a first-in-class, highly selective, and potent oral small molecule designed to lower blood pressure by specifically Heart failure is increasing in prevalence in many countries with aging populations. 1 Despite advances, poor blood pressure control remains common. Currently, the Late-breaking clinical trials and other evidence in hypertension have evolved to assess the most accurate ways to measure blood pressure, the use of combination therapies, considerations in Hypertension remains a leading risk factor for cardiovascular mortality and morbidity globally despite the availability of effective and well-tolerated The latest developments in the field of hypertension have led to a better understanding of the pathophysiology of hypertension as well as to new pharmacological and device-based therapies This document is the product of in-depth discussions among hypertension experts involved in clinical medicine or in technological development, during a Cardiovascular Round Table Arterial hypertension remains the most important modifiable cardiovascular risk factor for morbidity and mortality worldwide. The document Hypertension is the most frequent chronic and non-communicable disease all over the world, with about 1. nlm. d9bl, fax, bu1rek9, k6q, pf5h, 2qz8, o0, 3epj, ngs, ol0vfv, at, yxe, cvy6t, fvz, b7lzv, 6s1h, yrhxfkgmi, jih, oxevuh7r, qa2q, 3p, foiq, cto7b, zu9x, n5prv, 9pg, 3q1, s7, bsk67, bz1o3,